Komori
Business alliance2784Alfresa Holdings CorporationTrading & Wholesale

Business alliance between ArkMS株式会社 and 株式会社エムウィズ to expand the CRO business

ArkMS株式会社 and 株式会社エムウィズ have entered into a business alliance covering safety-related operations and sales activities for pharmaceuticals and medical devices. By leveraging the two companies’ specialist personnel and sales networks, the alliance will expand their service capabilities and business proposal opportunities in areas including PMS, PV and medical writing.

Worth reading
38Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Agreements reached under this partnership

Business alliance
2784Alfresa Holdings Corporation
Alliance partner株式会社エムウィズ
Details of the alliance
  1. 1

    Medical writing services

  2. 2

    Planning support services related to PMS

  3. 3

    Consulting services related to PV and PMS

  4. 4

    Production of materials and other items related to RMPs or the provision of information for appropriate use

  5. 5

    Data management, statistical and analysis services

  6. 6

    Other services agreed upon by the two companies

These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.

About the partner
Business DescriptionMedical writing, GVP/GPSP consulting, production of RMP-related materials and other services
LocationNishi-ku, Osaka, Osaka Prefecture
Share capital¥9 million
Impact on Business Performance

The impact of this transaction on results for the current fiscal year is expected to be immaterial, but over the medium to long term, it is expected to contribute to increasing the corporate value of the Group.

Contract Date31 March 2026
Agreements reached under this partnership
ItemDetails
Name of alliance partner株式会社エムウィズ
Alliance partner's business activitiesMedical writing, GVP/GPSP consulting, production of RMP-related materials and other services
Alliance partner's locationNishi-ku, Osaka, Osaka Prefecture
Alliance partner's capital¥9 million
Type of allianceBusiness alliance
Details of the allianceMedical writing services, Planning support services related to PMS, Consulting services related to PV and PMS, Production of materials and other items related to RMPs or the provision of information for appropriate use, Data management, statistical and analysis services, Other services agreed upon by the two companies
Contract Date31 March 2026
Impact on Business PerformanceThe impact of this transaction on results for the current fiscal year is expected to be immaterial, but over the medium to long term, it is expected to contribute to increasing the corporate value of the Group.
Items this document does not state (15)
Alliance partner's net salesAlliance partner's operating incomeNumber of shares acquiredAcquisition priceShareholding ratioOverview of the joint ventureOwnership ratioDispatch of directors and officersContract PeriodNumerical targets under the allianceShareholding PolicyDate of board resolutionAlliance start dateShare Acquisition Date and Payment DateChange in major shareholders

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To bring together the specialist personnel of both companies, who have practical experience at pharmaceutical companies, in order to strengthen their capabilities, quality and proposal expertise in areas including PMS, PV and medical writing, while sharing sales networks to expand proposal opportunities for existing customers and opportunities for new business discussions.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Business alliance between ArkMS株式会社 and 株式会社エムウィズ to expand the CRO business | Alfresa Holdings Corporation (2784) timely disclosure | Komori